




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiovascular Care Team</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=77363932-163e-4e60-acc9-30166483412d</link>
        <description>Clinical Topic Feed: Cardiovascular Care Team</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Maintaining Weight Loss With Tirzepatide</title>
<link>/Latest-in-Cardiology/Articles/2026/05/27/15/57/eagles-eye-view-27may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle examines recent research into maintaining weight loss with tirzepatide. He then offers insights into the new dyslipidemia guidelines, including addressing reproductive and hormone risk factors in cardiovascular risk assessment.</description>
                    <pubdate>1779898740000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: AI in the CICU: Transforming Cardiac Critical Care</title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/cardiacast_22may2026</link>                    <description>In this episode, hosts Rosy Thachil, MD, FACC, and Shashank Sinha, MD, FACC, are joined by Jacob Jentzer, MD, FACC, and Ami Bhatt, MD, FACC, Chief Innovation Officer of the American College of Cardiology, for an engaging discussion on AI in the CICU: Transforming Cardiac Critical Care.</description>
                    <pubdate>1779463800000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>DIGIT-HF Analysis and DECISION Analysis: New Insights on Digitoxin and Digoxin</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/DIGIT-HF-Analysis-and-DECISION-Analysis</link>                    <description>Digitoxin appears to be safe and effective in patients with heart failure with reduced ejection fraction (HFrEF), including those with atrial fibrillation (AFib), according to an analysis from DIGIT-HF, while digoxin discontinuation after long-term treatment was associated with clinical deterioration in patients with HF and LVEF &#226;‰&#164;50%, according to an analysis from DECISION. Both were published recently in EHJ.</description>
                    <pubdate>1779370200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>PRAISE-MR: Sacubitril/Valsartan Improves Exercise Hemodynamics, Oxygen Consumption</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/18/18/10/PRAISE-MR</link>                    <description>In patients with atrial functional mitral regurgitation (AFMR) and heart failure with reduced ejection fraction (HFpEF), sacubitril/valsartan was associated with improvements in exercise hemodynamics and peak oxygen consumption (VO2), along with attenuation of an exercised-induced increase in AFMR...</description>
                    <pubdate>1779370200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Spotlight Issue Provides Expert Insight on 2026 Dyslipidemia Guideline</title>
<link>/Latest-in-Cardiology/Articles/2026/05/19/15/49/JACC-Spotlight-Issue-2026-Dyslipidemia-Guideline</link>                    <description>A special JACC Spotlight Issue supporting the recently published 2026 ACC/AHA Guideline on the Management of Dyslipidemia, offers commentaries that provide a comprehensive overview of the new guideline recommendations and expert insights into understanding the science behind the recommendations...</description>
                    <pubdate>1779206040000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>The P&#39;s and Q&#39;s Disagree on a Child&#39;s ECG</title>
<link>/Education-and-Meetings/Patient-Case-Quizzes/2026/05/18/10/22/The-Ps-and-Qs-Disagree-on-a-Childs-ECG</link>                    <description>A previously healthy 6-year-old boy presents to the emergency department for treatment of a forearm laceration he sustained while playing in school. He has no history of syncope or recent illness. A detailed cardiac family history has unremarkable findings, including the absence of any autoimmune conditions.</description>
                    <pubdate>1779118380000</pubdate>
                    <category>Educational Activities</category>
                </item>
                <item>
                    <title>ACC CardiaCast: In Case You Missed It: ACC.26 ATTR-CM Treatment Updates</title>
<link>/Latest-in-Cardiology/Articles/2026/05/15/12/43/cardiacast_18may2026</link>                    <description>This CardiaCast episode explores the latest advances in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at ACC.26, with a focused review of newly released late-stage clinical trial data for currently available disease-modifying therapies.</description>
                    <pubdate>1779118200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>ACC CardiaCast: The Evolving Role of PCSK9 Inhibitors in LDL-C Management</title>
<link>/Latest-in-Cardiology/Articles/2026/05/14/13/14/cardiacast_15may2026</link>                    <description>In this episode of CardiaCast, Dr. Michael Blaha will be joined by Dr. Ann Marie Navar to discuss the 2026 updates to ACC/AHA guideline on management of dyslipidemia and key clinical trial data supporting the use of PCSK9 inhibitors in getting patients to their lipid goals.</description>
                    <pubdate>1778859000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Clinical Obesity Emerges as Independent Risk Factor For New-Onset HF, Mortality</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/14/17/42/Clinical Obesity</link>                    <description>A cohort study published May 4 in JACC: Asia identified clinical obesity as a risk factor for new-onset heart failure (HF) and all-cause mortality, largely due to related clinical conditions and excess weight. Treating clinical obesity as an independent disease may increase the effectiveness of HF prevention strategies.</description>
                    <pubdate>1778782020000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>